TEVA PHARMACEUTICAL INDUSTRIES LIMITED Toevoegen aan een lijst
Financiën Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Aandelen
TEVA
IL0006290147
Farmaceutische producten
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 6.065 ILa | -3,44% |
|
+2,29% | +58,98% |
| 01/07 | Sectorupdate: Gezondheidszorgaandelen trekken laat in de middag terug | MT |
| 01/07 | Sectorupdate: Aandelen in de gezondheidszorg dalen in de middaghandel | MT |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 10.702 | 10.576 | 8.835 | 10.129 | 11.703 | 18.552 | - | - |
| Bedrijfswaarde 1 | 35.634 | 34.318 | 29.713 | 28.540 | 28.310 | 33.533 | 30.997 | 28.453 |
| K/w-verhouding | -10,8 x | -2,65 x | 21,1 x | -4,3 x | -20,9 x | 17 x | 11,7 x | 9,39 x |
| Dividendrendement | - | - | - | - | - | - | - | - |
| Marktkapitalisatie/omzet | 0,63 x | 0,63 x | 0,56 x | 0,68 x | 0,74 x | 1,16 x | 1,12 x | 1,09 x |
| Bedrijfswaarde/omzet | 2,11 x | 2,06 x | 1,87 x | 1,91 x | 1,79 x | 2,1 x | 1,86 x | 1,67 x |
| Bedrijfswaarde/EBITDA | 7,61 x | 6,99 x | 6,05 x | 6,21 x | 5,88 x | 7,03 x | 6,08 x | 5,35 x |
| Bedrijfswaarde/FCF | 17,4 x | 53,8 x | 126 x | 27,4 x | 33,6 x | 14,1 x | 10 x | 8,36 x |
| FCF Yield | 5,76% | 1,86% | 0,79% | 3,65% | 2,97% | 7,08% | 9,99% | 12% |
| Price to Book | 0,77 x | 1,05 x | 0,86 x | 1,28 x | 1,56 x | 1,97 x | 1,57 x | 1,29 x |
| Aantal aandelen (in duizenden) | 1.092.089 | 1.095.972 | 1.103.007 | 1.110.645 | 1.120.971 | 1.132.592 | - | - |
| Referentieprijs 2 | 9,800 | 9,650 | 8,010 | 9,120 | 10,44 | 16,38 | 16,38 | 16,38 |
| Datum van publicatie | 12/02/20 | 10/02/21 | 9/02/22 | 8/02/23 | 31/01/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 16.887 | 16.659 | 15.878 | 14.925 | 15.846 | 16.002 | 16.625 | 17.048 |
| EBITDA 1 | 4.685 | 4.912 | 4.911 | 4.598 | 4.818 | 4.769 | 5.102 | 5.317 |
| Bedrijfsresultaat (EBIT) 1 | 4.142 | 4.388 | 4.401 | 4.139 | 4.361 | 4.285 | 4.660 | 4.836 |
| Operationele Marge | 24,53% | 26,34% | 27,72% | 27,73% | 27,52% | 26,78% | 28,03% | 28,37% |
| Resultaat voor belastingen (EBT) 1 | -1.265 | -4.406 | 658 | - | -624 | -99 | 3.194 | 3.302 |
| Nettowinst (verlies) 1 | -999 | -3.990 | 417 | -2.353 | -559 | 809,1 | 1.375 | 1.610 |
| Nettomarge | -5,92% | -23,95% | 2,63% | -15,77% | -3,53% | 5,06% | 8,27% | 9,45% |
| WPA 2 | -0,9100 | -3,640 | 0,3800 | -2,120 | -0,5000 | 0,9616 | 1,399 | 1,745 |
| Free Cash Flow 1 | 2.053 | 638 | 236 | 1.042 | 842 | 2.375 | 3.097 | 3.403 |
| FCF-marge | 12,16% | 3,83% | 1,49% | 6,98% | 5,31% | 14,84% | 18,63% | 19,96% |
| Kasstroomconversie (ebitda) | 43,82% | 12,99% | 4,81% | 22,66% | 17,48% | 49,8% | 60,7% | 64,02% |
| Kasstroomconversie (nettowinst) | - | - | 56,59% | - | - | 293,5% | 225,16% | 211,34% |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - |
| Datum van publicatie | 12/02/20 | 10/02/21 | 9/02/22 | 8/02/23 | 31/01/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 4.100 | 3.661 | 3.786 | 3.595 | 3.884 | 3.661 | 3.878 | 3.850 | 4.457 | 3.819 | 4.040 | 4.039 | 4.109 | 3.845 | 3.976 |
| EBITDA 1 | 1.373 | 1.135 | 1.134 | 1.089 | 1.240 | 899 | 1.125 | 1.134 | 1.660 | 1.005 | 1.137 | 1.220 | 1.361 | - | - |
| Bedrijfsresultaat (EBIT) 1 | 1.248 | 1.013 | 1.019 | 977 | 1.130 | 785 | 1.011 | 1.020 | 1.546 | 892 | 1.027 | 1.108 | 1.211 | 949,3 | 1.090 |
| Operationele Marge | 30,44% | 27,67% | 26,91% | 27,18% | 29,09% | 21,44% | 26,07% | 26,49% | 34,69% | 23,36% | 25,42% | 27,43% | 29,47% | 24,69% | 27,43% |
| Resultaat voor belastingen (EBT) 1 | -175 | -971 | -1.160 | - | -1.100 | - | - | 75 | 507 | -467 | 107 | 127 | 133 | - | - |
| Nettowinst (verlies) 1 | -159 | -955 | -232 | 56 | -1.221 | -205 | -863 | 80 | 461 | -139 | 39 | 56,5 | -15,77 | - | - |
| Nettomarge | -3,88% | -26,09% | -6,13% | 1,56% | -31,44% | -5,6% | -22,25% | 2,08% | 10,34% | -3,64% | 0,97% | 1,4% | -0,38% | - | - |
| WPA 2 | -0,1400 | -0,8600 | -0,2100 | 0,0500 | -1,100 | -0,1800 | -0,7700 | 0,0700 | 0,4100 | -0,1200 | -0,4009 | 0,002380 | 0,8995 | - | - |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 9/02/22 | 3/05/22 | 26/07/22 | 3/11/22 | 8/02/23 | 10/05/23 | 2/08/23 | 8/11/23 | 31/01/24 | 8/05/24 | - | - | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 24.932 | 23.742 | 20.878 | 18.411 | 16.607 | 14.981 | 12.445 | 9.901 |
| Nettokaspositie 1 | - | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 5,322 x | 4,833 x | 4,251 x | 4,004 x | 3,447 x | 3,141 x | 2,439 x | 1,862 x |
| Free Cash Flow 1 | 2.053 | 638 | 236 | 1.042 | 842 | 2.375 | 3.097 | 3.403 |
| ROE (netto-inkomsten/eigen vermogen) | 18,3% | 11,8% | 28,1% | 30,9% | 37,9% | 28,9% | 30,1% | 26,1% |
| ROA (netto-inkomsten/totale activa) | 4,45% | 5,24% | 5,81% | 6,13% | 6,62% | 2,94% | 5,17% | 4,69% |
| Totale activa 1 | -22.466 | -76.212 | 7.179 | -38.354 | -8.438 | 27.507 | 26.624 | 34.356 |
| Nettoactief per aandeel 2 | 12,80 | 9,160 | 9,320 | 7,110 | 6,710 | 8,320 | 10,50 | 12,70 |
| Cashflow per aandeel 2 | 0,6900 | 1,110 | 0,7200 | 1,430 | 1,220 | 2,490 | 2,860 | 3,250 |
| Capex 1 | 525 | 578 | 562 | 548 | 526 | 519 | 547 | 562 |
| Capex/omzet | 3,11% | 3,47% | 3,54% | 3,67% | 3,32% | 3,24% | 3,29% | 3,3% |
| Datum van publicatie | 12/02/20 | 10/02/21 | 9/02/22 | 8/02/23 | 31/01/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
13
Laatste slotkoers
16,38
USD
Gemiddelde koersdoel
18,94
USD
Spread / Gemiddelde doel
+15,60%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +55,35% | 815 mld. | |
| +31,64% | 597 mld. | |
| -0,10% | 377 mld. | |
| +15,47% | 319 mld. | |
| +13,10% | 310 mld. | |
| +15,51% | 247 mld. | |
| +16,72% | 228 mld. | |
| +16,54% | 180 mld. | |
| +4,31% | 170 mld. |
- Beurs
- Aandelen
- Koers TEVA
- Koers TEVA
- Financiën Teva Pharmaceutical Industries Limited
